Infliximab-induced palmoplantar psoriasis in a patient with ankylosing spondylitis

Journal of Clinical Rheumatology

Volumn 17, Issue 5, 2011, Pages 293-294

  Çapkin, Erhan ^a   Karkucak, Murat ^a   Yayli, Savaş ^a   Aydin Çapkin, Arzu ^a   Tosun, Mehmet ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INFLIXIMAB; METHOTREXATE;

ADULT; ANKYLOSING SPONDYLITIS; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MONOTHERAPY; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS; SCORING SYSTEM; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; FOOT; HAND; HUMANS; PSORIASIS; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80051747789     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318228bcb6     Document Type: Letter

References (11)

1. Bal A, Gurcay E, Aydog E, et al. Onset of psoriasis induced by infliximab. J Clin Rheum. 2008;14:353-356.
2. Bosch R, Amo NV, Manteca CF, et al. Psoriasis induced by anti-TNF probably not so uncommon. J Clin Rheum. 2008;14:353-356.
3. Cuchacovich R, Espinoza CG, Virk Z, et al. Biologic therapy (TNF-α antagonists) Yinduced psoriasis. A cytokine imbalance between TNF-α and IFN-α? J Clin Rheum. 2008;14:353-356.
4. Temekonidis TI, Alamanos Y, Nikas NS, et al. Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study. Ann Rheum Dis. 2003;62:1218-1220. (Pubitemid 37500631)
5. Braun J, Sieper J. Biological therapies in the spondyloarthritides - the current state. Rheumatology (Oxford). 2004;43:1072-1084. (Pubitemid 39232810)
6. Tobin AM, Kirby B. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis. Biodrugs. 2005;19:47-57. (Pubitemid 40432507)
7. Moustou AE, Matekovits A, Dessinioti C, et al. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol. 2009;61:486-504.
8. Wollina U, Hansel G, Koch A, et al. Tumor necrosis factor-α inhibitor-induced psoriasis or psoriasiform exanthemata. Am J Clin Dermatol. 2008;9:1-14.
9. Pichler WJ, Yawalkar N, Britschgi M, et al. Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol. 2002;3:229-238. (Pubitemid 34615386)
10. Wollina U, Knopf B, Klinger R. Topical interferon-alpha in psoriasis increases epidermal calmodulin activity. Arch Dermatol Res. 1990;282:270-271. (Pubitemid 20205652)
11. Collamer AN, Guerrero KT, Henning JS, et al. Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action. Arthritis Rheum. 2008;59:996-1001. (Pubitemid 351990997)